MDWD logo

MDWDMediWound Ltd

$14.09
$0.23
(1.66%)
Today
Closed $14.09
$0.00
(0.00%)
After Hours
Updated: 06:28 PM EDT
Reported EarningsMay 27
Mkt Cap$178.04M
Vol74,834.00
40

Bearish Sentiment

How do you feel about MDWD?

News
all
press releases
Oversold Conditions For Mediwound (MDWD)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
MediWound (MDWD) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
MediWound Reports Q1 2026 Results: Full Earnings Call Transcript
read more...
Benzinga
News Placeholder
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of +64.79% and -56.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates
NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of +20.00% and -91.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Misses Revenue Estimates
Biorestorative Therapies (BRTX) delivered earnings and revenue surprises of +36.67% and -53.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of -14.29% and +5.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates
Profound Medical (PROF) delivered earnings and revenue surprises of +21.91% and +4.79%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Rating of "Hold" by Analysts
MediWound Ltd. (NASDAQ:MDWD - Get Free Report) has been given a consensus rating of "Hold" by the five research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to t...
MarketBeat
News Placeholder
MediWound (NASDAQ:MDWD) Share Price Crosses Above Fifty Day Moving Average - Time to Sell?
MediWound (NASDAQ:MDWD) Shares Cross Above Fifty Day Moving Average - Time to Sell...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.